Healthcare Services company Dr. Lal Pathlabs announced Q4FY26 results Revenue increased by 16.6% in Q4FY26. EBITDA for Q4FY26 increased by 10.5% with a margin of 26.6%. PAT for Q4FY26 is Rs 132 crore. with a margin for of 18.8%. Final Dividend of 40% i.e. Rs. 4 per share. Cash and Cash equivalents as on 31st March, 2026 is Rs. 1,526 crore. Result PDF